Hepatocellular Adenoma

  • Giorgio ErcolaniEmail author
  • Chiara Zanfi
  • Matteo Cescon
  • Antonio Daniele Pinna


Hepatocellular adenoma is one of the benign tumors which may occur in the liver. Solitary adenoma is more frequent in women, especially associated with the use of oral contraceptives or anabolic steroids. Glycogen storage disease and mutation of HNF1A gene are associated with an increased incidence of adenomas. It is usually asymptomatic and found incidentally. MRI is used to suspect the diagnosis which should be confirmed by liver biopsy. Recently, adenomas have been usually divided in four types with different characteristics (Bordeaux classification): adenoma with HFN1A gene mutation, adenoma with B-catenin gene mutation, adenoma without any markers, and inflammatory adenomas. It has been reported with an increasing risk of bleeding (up to 25 %) or tumor transformation (up to 9 %) based on histologic classification (B-catenin mutation) and size. Surgical resection is usually recommended in case of tumor size larger than 5 cm, B-catenin mutation, presence of symptoms, evidence of dysplasia or atypia at the biopsy, or features of malignant transformation (increase size at the follow-up). Early postoperative outcome after partial hepatectomy has been reported excellent as well as long-term results. In case of adenomatosis (more than ten adenoma), surgical resection of the greatest lesions may be recommended; however, liver transplantation may be considered in case of diffuse disease, and it has been reported as an exceptional indication in 0.09 % of all indications in the world.


Benign liver tumor Hepatocellular adenoma Adenomatosis Complications Surgical resection 


  1. 1.
    Flejou JF, Barge J, Menu Y et al (1985) Liver adenomatosis: an entity distinct from liver adenoma? Gastroenterology 89:1132–1138PubMedGoogle Scholar
  2. 2.
    Farges O, Ferreira N, Dokmak S et al (2011) Changing trends in malignant transformation of hepatocellular adenoma. Gut 60:85–89CrossRefPubMedGoogle Scholar
  3. 3.
    Jeannot E, Wendum D, Paye F, Mourra N, de Toma C, Flejou JF, Zucman-Rossi J (2006) Hepatocellular adenoma displaying a HNF1alpha inactivation in a patient with familial adenomatous polyposis coli. J Hepatol 45(6):883–886CrossRefPubMedCentralPubMedGoogle Scholar
  4. 4.
    Rooks JB, Ory HW, Ishak KG, Strauss LT, Greenspan JR, Hill AP, Tyler CW (1979) Epidemiology of hepatocellular adenoma. The role of oral contraceptives. JAMA 242(7):644–648CrossRefPubMedGoogle Scholar
  5. 5.
    Lin H, Van den Esschert J, Liu C, Van Gulik T (2011) Systematic review of hepatocellular adenoma in China and other regions. J Gastroenterol Hepatol 26:28–35CrossRefPubMedGoogle Scholar
  6. 6.
    Lee PJ (2002) Glycogen storage disease type I: pathophysiology of liver adenomas. Eur J Pediatr 161(Suppl 1):S46–S49CrossRefPubMedGoogle Scholar
  7. 7.
    Steinbrecher UP, Lisbona R, Huang SN, Mishikin S (1981) Complete regression of hepatocellular adenoma after withdrawal of oral contraceptives. Dig Dis Sci 26(11):1045–1050CrossRefPubMedGoogle Scholar
  8. 8.
    Torbeson M, Lee JH, Choti M, Gage W, Abraham SC, Montgomery E, Boitnott J, Wu TT (2002) Hepatic adenomas: analysis of sex steroid receptor status and the Wnt signalling pathway. Mod Pathol 15(3):189–196CrossRefGoogle Scholar
  9. 9.
    Labrune P, Trioche P, Duvaltier I, Chevalier P, Odievre M (1997) Hepatocellular adenomas in glycogen storage disease type I and III: a series of 43 patients and review of the literature. J Pediatr Gastroenterol Nutr 24(3):276–279CrossRefPubMedGoogle Scholar
  10. 10.
    Demo E, Frush D, Gottfried M, Koepke J, Boney A, Bali D, Chen YT, Kishnani PS (2007) Glycogen storage disease type III-hepatocellular carcinoma a long term complication? J Hepatol 46(3):492–498CrossRefPubMedCentralPubMedGoogle Scholar
  11. 11.
    Bannasch P, Mayer D, Hacker HJ (1980) Hepatocellular glycogenosis and hepatocarcinogenesis. Biochim Biophys Acta 605(2):217–245PubMedGoogle Scholar
  12. 12.
    Pelletier L, Rebouissou S, Paris A et al (2010) Loss of HNF1αfunction in human hepatocellular adenomas leads to aberrant activation os signaling pathways involved in tumorigenesis. Hepatology 51:557–566CrossRefPubMedGoogle Scholar
  13. 13.
    Rebouissou S, Amessou M, Couchy G, Poussin K, Imbeaud S, Pilati C et al (2009) Frequent inframe somatic deletion activate gp130 in inflammatory hepatocellular tumors. Nature 57:200–204CrossRefGoogle Scholar
  14. 14.
    Zucman-Rossi J, Jeannot E, Nhieu JT, Scoazec JY, Guettier C, Rebouissou S et al (2006) Genotype-phenotype correlation in hepatocellular adenoma: new classification and relationship with HCC. Hepatology 43:515–524CrossRefPubMedGoogle Scholar
  15. 15.
    Bioulac-Sage P, Rebouissou S, Thomas C, Blanc JF, Saric J et al (2007) Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry. Hepatology 46:740–748CrossRefPubMedGoogle Scholar
  16. 16.
    Bioulac-Sage P, Laumonier H, Couchy G, Le Bail B et al (2009) Hepatocellular adenoma management and phenotypic classification: the Bordeaux experience. Hepatology 50:481–489CrossRefPubMedGoogle Scholar
  17. 17.
    Cobey FC, Salem RR (2004) A review of liver masses in pregnancy and a proposed algorithm for their diagnosis and management. Am J Surg 187:181–191CrossRefPubMedGoogle Scholar
  18. 18.
    Edmondson HA, Henderson B, Benton B (1976) Liver cell adenomas associated with use of oral contraceptives. N Engl J Med 294:470–472CrossRefPubMedGoogle Scholar
  19. 19.
    Kerlin P, Davis GL, McGill DB, Weiland LH et al (1983) Hepatic adenoma and focal nodular hyperplasia: clinical, pathologic and radiologic features. Gastroenterology 84:994–1002PubMedGoogle Scholar
  20. 20.
    Mathieu D, Bruneton JN, Drouillard J et al (1986) Hepatic adenomas and focal nodular hyperplasia: dynamic CT study. Radiology 160:53–58CrossRefPubMedGoogle Scholar
  21. 21.
    Leese T, Farges O, Bismuth H (1988) Liver cell adenomas: a 12-year surgical experience from a specialist hepatobiliary unit. Ann Surg 208:558–564CrossRefPubMedCentralPubMedGoogle Scholar
  22. 22.
    Iwatsuki S, Todo S, Starzl TE (1990) Excisional therapy for benign hepatic lesions. Surg Gynecol Obstet 171:240–246PubMedCentralPubMedGoogle Scholar
  23. 23.
    Arrive L, Flejou JF, Vilgrain V et al (1994) Hepatic adenoma: MR findings in 51 pathologically proved lesions. Radiology 193:507–512CrossRefPubMedGoogle Scholar
  24. 24.
    Pertschy J, Ruckert JC, Manger T (1994) Diagnosis and surgical therapy of benign liver tumors. Zentralbl Chir 119:495–500PubMedGoogle Scholar
  25. 25.
    Chung J, Ferzli G, David A, Kiel T (1995) Laparoscopic resection of a large hepatic tumor. Surg Endosc 9:733–735CrossRefGoogle Scholar
  26. 26.
    Nagorney DM (1995) Benign hepatic tumors: focal nodular hyperplasia and hepatocellular adenoma. World J Surg 19:13–18CrossRefPubMedGoogle Scholar
  27. 27.
    De Carlis L, Pirotta V, Rondinara GF et al (1997) Hepatic adenoma and focal nodular hyperplasia: diagnosis and criteria for treatment. Liver Transpl Surg 3:160–165CrossRefPubMedGoogle Scholar
  28. 28.
    Ott R, Hohenberger W (1998) Focal nodular hyperplasia and liver cell adenoma: operation or observation? Zentralbl Chir 123:145–153PubMedGoogle Scholar
  29. 29.
    Closset J, Veys I, Peny MO et al (2000) Retrospective analysis of 29 patients surgically treated for hepatocellular adenoma or focal nodular hyperplasia. Hepatogastroenterology 47:1382–1384PubMedGoogle Scholar
  30. 30.
    Ichikawa T, Federle MP, Grazioli L et al (2000) Hepatocellular adenoma: multiphasic CT and histopathologic findings in 25 patients. Radiology 214:861–868CrossRefPubMedGoogle Scholar
  31. 31.
    Reddy KR, Kligerman S, Levi J et al (2001) Benign and solid tumors of the liver: relationship to sex, age, size of tumors and outcome. Am Surg 67:173–178PubMedGoogle Scholar
  32. 32.
    Terkivatan T, de Witt JH, de Man RA et al (2001) Indications and long term outcome of treatment for benign hepatic tumors: a critical appraisal. Arch Surg 136:1033–1038CrossRefPubMedGoogle Scholar
  33. 33.
    Descottes B, Glineur D, Lachachi F et al (2003) Laparoscopic liver resection of benign liver tumors. Surg Endosc 17:23–30CrossRefPubMedGoogle Scholar
  34. 34.
    Toso C, Majno P, Andreas A et al (2005) Management of hepatocellular adenoma: solitary uncomplicated, multiple and ruptured tumors. World J Gastroenterol 11:5691–5695PubMedGoogle Scholar
  35. 35.
    Erdogan D, Busch OR, van Delden OM et al (2006) Management of spontaneous haemorrhage and rupture of hepatocellular adenomas. A single centre experience. Liver Int 26:433–438CrossRefPubMedGoogle Scholar
  36. 36.
    Van der Windt DJ, Kok NF, Hussain SM et al (2006) Case-oriented approach to the management of hepatocellular adenoma. Br J Surg 93:1495–1502CrossRefPubMedGoogle Scholar
  37. 37.
    Chaib E, Gama-Rodrigues J, Ribeiro MA et al (2007) Hepatic adenoma. Timing for surgery. Hepatogastroenterology 54:1382–1387PubMedGoogle Scholar
  38. 38.
    Koffron AJ, Auffenberg G, Kung R, Abecassis M (2007) Evaluation of 300 minimally invasive liver resections at a single institution: less is more. Ann Surg 246:385–392; discussion 92–94CrossRefPubMedCentralPubMedGoogle Scholar
  39. 39.
    Reddy SK, Kishnani PS, Sullivan JA et al (2007) Resection of hepatocellular adenoma in patients with glycogen storage disease type Ia. J Hepatol 47:658–663CrossRefPubMedGoogle Scholar
  40. 40.
    Buell JF, Thomas MT, Rudich S et al (2008) Experience with more than 500 minimally invasive hepatic procedures. Ann Surg 248:475–486PubMedGoogle Scholar
  41. 41.
    Cho SW, Marsh JW, Steel J et al (2008) Surgical management of hepatocellular adenoma: take it or leave it? Ann Surg Oncol 15:2795–2803CrossRefPubMedGoogle Scholar
  42. 42.
    Petri A, Hohn J, Kokai EL et al (2008) Surgery of benign liver tumors: indications for treatment: twenty years’ experience. Hepatogastroenterology 55:592–595PubMedGoogle Scholar
  43. 43.
    Deneve JL, Pawlik TM, Cunningham S et al (2009) Liver cell adenoma management: a multicenter analysis of risk factors for rupture and malignancy. Ann Surg Oncol 16:640–648CrossRefPubMedGoogle Scholar
  44. 44.
    Dokmak S, Paradis V, Vilgrain V et al (2009) A single center surgical experience of 22 patients with single and multiple hepatocellular adenomas. Gastroenterology 137:1698–1705CrossRefPubMedGoogle Scholar
  45. 45.
    Mounajjed T, Wu TT (2011) Telangiectatic variant of hepatic adenoma: clinicopathologic features and correlation between liver needle biopsy and resection. Am J Surg Pathol 35:1356–1363CrossRefPubMedGoogle Scholar
  46. 46.
    Bunchorntavakul C, Bahirwani R, Drazek D et al (2011) Clinical features and natural history of hepatocellular adenomas: the impact of obesity. Aliment Pharmacol Ther 34:664–667CrossRefPubMedGoogle Scholar
  47. 47.
    De Angelis N, Memeo R, Calderaro J et al (2014) Open and laparoscopic resection of hepatocellular adenoma: trends over 23 years at a specialist hepatobiliary unit. HPB (Oxford) 16(9):783–788CrossRefGoogle Scholar
  48. 48.
    Foster JH, Berman NN (1994) The malignant transformation of liver cell adenomas. Arch Surg 129:712–717CrossRefPubMedGoogle Scholar
  49. 49.
    Lepreux S, Laurent C, Blanc JF, Trillaud H, Le Bail B et al (2003) The identification of small nodules in liver adenomatosis. J Hepatol 39:77–85CrossRefPubMedGoogle Scholar
  50. 50.
    Flowers BF, McBurney RP, Vera SR (1990) Ruptured hepatic adenoma. A spectrum of presentation and treatment. Am Surg 56:380–383PubMedGoogle Scholar
  51. 51.
    Akovbiantz A, Ackermann D, Buhler H, Schmid M (1980) Management of liver cell adenoma and focal nodular hyperplasia. Helv Chir Acta 47(5):607–609PubMedGoogle Scholar
  52. 52.
    Yoshidome H, McMasters KM, Edwards M (1999) Management issues regarding hepatic adenomatosis. Am Surg 65:1070–1076PubMedGoogle Scholar
  53. 53.
    Ribeiro A, Burgart LJ, Nagorney DM, Gores GJ (1998) Management of liver adenomatosis: results with a conservative surgical approach. Liver Transpl Surg 4:388–398CrossRefPubMedGoogle Scholar
  54. 54.
    Barthelmes L, Tait IS (2005) Liver cell adenoma and liver cell adenomatosis. HPB (Oxford) 7:186–196CrossRefGoogle Scholar
  55. 55.
    Tepetes K, Selby R, Webb M, Madariaga JR, Iwatsuki S, Starzl TE (1995) Orthotopic liver transplantation for benign hepatic neoplasms. Arch Surg 130:153–156CrossRefPubMedGoogle Scholar
  56. 56.
    Ercolani G, Grazi GL, Pinna AD (2010) Liver transplantation for benign hepatic tumors: a systematic review. Dig Surg 27:68–75CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG Switzerland 2015

Authors and Affiliations

  • Giorgio Ercolani
    • 1
    Email author
  • Chiara Zanfi
    • 1
  • Matteo Cescon
    • 1
  • Antonio Daniele Pinna
    • 1
  1. 1.Department of Emergency, Surgery and TransplantationSant’Orsola Hospital, University of BolognaBolognaItaly

Personalised recommendations